Skip to main content
. Author manuscript; available in PMC: 2009 Dec 2.
Published in final edited form as: Anticancer Res. 2009 Jun;29(6):1987–1992.

Figure 1.

Figure 1

Clonogenic cell survival of HT29 (a) and SCCVII (b) parental and clonal cell lines assessed 24 h after treatment with a range of doses of vandetanib. Data shown are the average of 2 independent experiments.